Cardinal Health, Inc. CAH
281.10 USD +2.96 (+1.06%)
Regular-session close
281.10 0.00 0.00%
After hours · Nov 13, 5:25 PM ET
276.75 Day range 281.86
182.50 52-week range 281.10
- YTD
- +36.79%
- 1 year
- +36.42%
News
zacks.com Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm…benzinga.com Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309 Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.
prnewswire.com Cardinal Health Board of Directors Approves Quarterly Dividend DUBLIN, Ohio, Nov. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital…
zacks.com Here's Why Cardinal Health (CAH) is a Great Momentum Stock to Buy Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
benzinga.com If You Invested $100 In Cardinal Health Stock 5 Years Ago, You Would Have This Much Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 30.64% on an annualized basis producing an average annual return of 40.55%. Currently, Cardinal Health has a market…
zacks.com Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
zacks.com 4 Stocks with Impressive Interest Coverage Ratios to Buy Now Stride, Ralph Lauren, Cardinal Health and Vertiv stand out for strong interest coverage ratios, earnings growth prospects and financial resilience.benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $286 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $260 to $286.
defenseworld.net CenterBook Partners LP Makes New Investment in Cardinal Health, Inc. $CAH CenterBook Partners LP bought a new position in Cardinal Health, Inc. (NYSE: CAH) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 4,979 shares of the…benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $304 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $304.
zacks.com Are Medical Stocks Lagging Cardinal Health (CAH) This Year? Here is how Cardinal Health (CAH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
zacks.com Should Value Investors Buy Cardinal Health (CAH) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
benzinga.com Jim Cramer Praises The 'Number One Oil Company In The World' On CNBC's “Mad Money Lightning Round,” Jim Cramer praised VF Corp (NYSE:VFC) and expects the stock to rise. Supporting his choice, VF posted better-than-expected second-quarter earnings on Oct. 28.
seekingalpha.com 69 Dividend Champions Ranked By Quality Scores (November 2026) I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued.…benzinga.com RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.
benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $320 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $270 to $320.
benzinga.com Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.
benzinga.com Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
benzinga.com Cardinal Health Q1 2027 Earnings Call Transcript Cardinal Health (NYSE:CAH) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Cardinal Health Q1 Adj. EPS $3.26 Beats $2.94 Estimate, Sales $67.513B Beat $66.588B Estimate Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $2.94 by 10.88 percent. This is a 27.84 percent increase over earnings of $2.55…
benzinga.com Cardinal Health Raises FY2027 Adj EPS Guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 Est Cardinal Health (NYSE:CAH) raises FY2027 Adj EPS guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 analyst estimate..
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q1 Earnings Cardinal Health expects Q1 EPS of $2.94 and revenue of $66.51B. Analysts remain bullish, raising price targets up to $295.
benzinga.com Dow Jumps Over 1,500 Points After Midterms: Investor Sentiment Improves, Greed Index Moves To ‘Fear’ Zone CNN Fear & Greed rose to 27 in the Fear zone as U.S. stocks surged after Democrats won Congress; oil fell and most sectors gained.
benzinga.com Qualcomm, US Foods And 3 Stocks To Watch Heading Into Thursday Stocks in focus: Cardinal Health and US Foods report earnings; Qualcomm and Snap shares fall after results; Airbnb reports after the close.
benzinga.com Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 29.24% on an annualized basis producing an average annual return of 39.65%. Currently, Cardinal Health has a market…
benzinga.com Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and…benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.
benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $295 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Cardinal Health, McKesson Double Down on CVS Deals Through 2032 Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.benzinga.com Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032 Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…benzinga.com RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276 RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
benzinga.com Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275 Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.
benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $280 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.
benzinga.com Cardinal Health Analysts Increase Their Forecasts Following Q4 Results Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates, but sales missing expectations. The company also raised its share repurchase authorization and…benzinga.com Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277 Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $245 to $277.
benzinga.com Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274 Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.
benzinga.com S&P 500 Falls for Second Session Ahead of Inflation Report: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Greed’ Zone CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks closed lower.
benzinga.com Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.
benzinga.com US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.benzinga.com Cardinal Health Announces $5B Incremental Share Buyback Authorization Cardinal Health recently completed an additional $350 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.4 billion.Cardinal Health Board…
benzinga.com Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investors await earnings results and CPI report.
benzinga.com Cardinal Health, Babcock & Wilcox Enterprises and 3 Stocks to Watch Heading Into Tuesday U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcock & Wilcox Enterprises Inc.
